Blog
About

0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Preoperative erythropoietin alpha (EPO) has been shown to be effective at reducing postoperative blood transfusions in total hip arthroplasty (THA) and total knee arthroplasty (TKA); however, treatment with EPO is associated with additional costs, and it is not known whether these costs can be justified when weighed against the transfusion reductions achieved in patients who receive the drug.

          Related collections

          Author and article information

          Journal
          Clin. Orthop. Relat. Res.
          Clinical orthopaedics and related research
          Springer Nature America, Inc
          1528-1132
          0009-921X
          Feb 2015
          : 473
          : 2
          Affiliations
          [1 ] Department of Orthopaedics, Massachusetts General Hospital, Boston, MA, USA, hbedair@partners.org.
          Article
          10.1007/s11999-014-3819-z
          4294940
          25106796

          Comments

          Comment on this article